Charles Schwab Investment Management Inc Enochian Biosciences Inc Transaction History
Charles Schwab Investment Management Inc
- $515 Billion
- Q3 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Enochian Biosciences Inc stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 198,966 shares of ENOB stock, worth $915,243. This represents 0.0% of its overall portfolio holdings.
Number of Shares
198,966
Previous 198,966
-0.0%
Holding current value
$915,243
Previous $915,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ENOB
# of Institutions
51Shares Held
14.7MCall Options Held
24KPut Options Held
19.1K-
Vanguard Group Inc Valley Forge, PA5.72MShares$26.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY3.66MShares$16.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.57MShares$7.23 Million0.0% of portfolio
-
State Street Corp Boston, MA1.32MShares$6.09 Million0.0% of portfolio
-
Northern Trust Corp Chicago, IL595KShares$2.74 Million0.0% of portfolio
About Enochian Biosciences Inc
- Ticker ENOB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,950,000
- Market Cap $244M
- Description
- Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...